Altimmune (ALT) Revenue (2010 - 2025)

Altimmune (ALT) reported Revenue of $26000.0 for Q4 2025, up 420.0% year-over-year from $5000.0 in Q4 2024, and up 420.0% quarter-over-quarter from $5000.0 in Q3 2025.

Altimmune (ALT) Revenue (2010 - 2025) Analysis & Trends

Altimmune (ALT) has 16 years of Revenue data on file, last reported at $26000.0 in Q4 2025.

  • Revenue for Q4 2025 came in at $26000.0, up 420.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $41000.0 (up 105.0% YoY), and the FY2025 annual result was $41000.0, up 105.0% from the prior year.
  • Revenue improved to $26000.0 in Q4 2025 per ALT's latest filing, from $5000.0 in the prior quarter.
  • Over five years, Revenue peaked at $3.3 million in Q4 2021 and troughed at $2000.0 in Q3 2022.
  • A 5-year average of $248250.0 and a median of $14500.0 in 2022 frame the typical range for Revenue.
  • The sharpest annual moves came in 2022 and 2023: Revenue tumbled 99.21% in 2022, then jumped 18000.0% in 2023.
  • A 5-year view of Revenue shows it stood at $3.3 million in 2021, then plunged by 99.21% to $26000.0 in 2022, then jumped by 42.31% to $37000.0 in 2023, then sank by 86.49% to $5000.0 in 2024, then surged by 420.0% to $26000.0 in 2025.
  • Business Quant data shows ALT's Revenue at $26000.0 in Q4 2025, $5000.0 in Q3 2025, and $5000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Altimmune 336.67 Mn 336.67 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 26,000.00
Sep 30, 2025 5,000.00
Jun 30, 2025 5,000.00
Mar 31, 2025 5,000.00
Dec 31, 2024 5,000.00
Sep 30, 2024 5,000.00
Jun 30, 2024 5,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 37,000.00
Sep 30, 2023 362,000.00
Jun 30, 2023 6,000.00
Mar 31, 2023 21,000.00
Dec 31, 2022 26,000.00
Sep 30, 2022 2,000.00
Jun 30, 2022 8,000.00
Mar 31, 2022 32,000.00
Dec 31, 2021 3.28 Mn
Sep 30, 2021 158,000.00
Jun 30, 2021 137,000.00
Mar 31, 2021 838,000.00